The Decision Tree
Answer these four questions to decide
Direct indexing is not for everyone. The following decision tree identifies whether you're in the group that benefits — or whether ETFs are the better choice.
Do you have $100K+ in a taxable brokerage account?
Yes → Continue to Question 2. Direct indexing needs sufficient capital for meaningful tax-loss harvesting.
No → Use ETFs. Below $100K, the annual tax savings ($500–$2,000) may not justify the fee premium. Some platforms accept $5K, but the benefit is slim. Exception: if your tax bracket is 37%+ and you expect to add capital quickly, starting at $50K can work.
Is your federal tax bracket 24% or higher?
Yes → Continue to Question 3. Higher brackets mean each dollar of harvested loss is worth more in tax savings.
No (22% or below) → Use ETFs. At the 22% bracket, a $10,000 harvested loss saves $2,200. After the fee premium (~$1,500/year on $500K), the net benefit is only $700. The complexity isn't justified.
Is your time horizon 5+ years?
Yes → Continue to Question 4. Tax alpha compounds over time and is front-loaded in years 1–3.
No (<5 years) → Consider ETFs. Direct indexing can work over 3–5 years, but the cumulative benefit may not significantly exceed ETFs. If you're planning to liquidate within 2 years, the fee premium is unlikely to be recovered.
Do you have specific customization needs?
Yes (employer stock exclusion, ESG, factor tilts) → Direct indexing is a clear fit. The customization alone justifies the strategy, and tax alpha is a bonus.
No → Direct indexing is still likely beneficial based on your tax bracket and portfolio size, but the primary value is tax-loss harvesting alone. If the net annual benefit after fees exceeds $2,000, proceed.
The Math Check
Calculate your expected net benefit before committing
Before opening a direct indexing account, run this simple calculation:
Step 1: Estimate annual tax alpha
• 22–24% bracket: use 0.7% estimate
• 32% bracket: use 1.2% estimate
• 35–37% bracket: use 1.5% estimate
• Add 0.2% if in a high-tax state (CA, NY, NJ, OR, MN)
Step 2: Calculate annual tax savings
Taxable portfolio × estimated tax alpha = annual tax savings
Example: $500,000 × 1.5% = $7,500/year
Step 3: Calculate incremental fee
(DI fee − ETF fee) × taxable portfolio = annual incremental cost
Example: (0.35% − 0.03%) × $500,000 = $1,600/year
Step 4: Net benefit
Annual tax savings − incremental fee = net annual benefit
Example: $7,500 − $1,600 = $5,900/year net benefit
Decision rule: If the net annual benefit exceeds $2,000, direct indexing is clearly worth it. Between $500–$2,000, it's marginal — consider customization needs as a tiebreaker. Below $500, stick with ETFs.
Quick Calculator: Three Investor Profiles
Low Bracket, Small Portfolio
$200/year
22% bracket, $100K portfolio, 0.35% DI fee
Tax alpha: $700/year. Incremental fee: $320/year. Net: $380. Not worth the complexity. Use ETFs.
High Bracket, Large Portfolio
$13,200/year
37% bracket, $1M portfolio, 0.20% DI fee
Tax alpha: $15,000/year. Incremental fee: $1,700/year. Net: $13,300. Clear winner. Over 10 years: $133,000+ in net savings.
The Breakeven: At the 32% bracket, the breakeven portfolio size for direct indexing (where net benefit > $2,000/year) is approximately $200,000 in taxable accounts. Below that, ETFs win on simplicity and cost.
Concentrated Stock
If you hold concentrated stock, the checklist has a second part
The decision tree above covers the diversified portion of your portfolio. If you also hold a concentrated stock position (>20% of net worth in a single stock), you need a separate strategy for that holding.
Do you hold $500K+ in a single stock with unrealized gains?
If yes, direct indexing alone is insufficient. It optimizes the portfolio around the concentrated position but doesn't address the position itself. You need a dedicated concentrated stock strategy.
Is the embedded gain >$200K?
If the tax cost of selling exceeds $200K (roughly $850K+ in unrealized gain at 23.8% LTCG + NIIT), the concentrated position deserves a tax-deferral strategy — not just loss harvesting on other holdings.
Do you want income from the position without selling?
Direct indexing generates no income from concentrated stock. Embark's §721 SPV can generate targeted 10%+ income on the position through partnership-level strategies, with the contribution tax-deferred under §721(a).
Are you an accredited investor ($1M+ net worth or $200K+ income)?
Most concentrated stock strategies (including Embark's SPV, exchange funds, and structured products) require accredited investor status. If you meet this threshold and hold concentrated stock, explore these options.
The recommended pairing:
• Diversified portfolio → Direct indexing (tax-loss harvesting, stock exclusion, customization)
• Concentrated position → Embark §721 SPV (tax-deferred contribution, income generation, upside preservation)
• Tax-advantaged accounts → Low-cost ETFs (no TLH benefit, so minimize fees)
Free Weekly Insights
Get This Analysis Every Week
Join investors at Google, Amazon & Apple who stay ahead with Embark’s weekly insights on concentrated stock strategies.
No spam. Unsubscribe anytime.
Platform Guide
Which direct indexing platform based on your profile
Once you've decided direct indexing fits, choosing the platform is straightforward:
Under $100K Taxable
WealthfrontWealthfront S&P 500 Direct at $5K minimum and 0.09% fee is the lowest-cost entry point. Limited to S&P 500 only. Good for cost-conscious investors starting direct indexing.
$100K–$250K Taxable
Schwab or AperioSchwab Personalized Indexing ($100K min, 0.40%) offers 6 index strategies. Aperio by BlackRock ($100K, 0.25–0.35%) offers deep ESG and factor customization. Good for investors who want options beyond S&P 500.
$250K–$1M Taxable
Vanguard or ParametricVanguard Personalized Indexing ($250K min, 0.20%) is lowest cost at scale. Parametric ($250K, 0.20–0.35%) is the industry pioneer with the most customization. Both offer multi-index capabilities.
$1M+ Taxable + Concentrated Stock
Parametric + Embark SPVUse Parametric (or any full-service platform) for the diversified portion. Pair with Embark's §721 SPV for the concentrated stock position. This combination maximizes both tax-loss harvesting and capital gains deferral.
Quick Reference
The one-page summary: who should use what
| Your Situation | Best Strategy | Why |
|---|---|---|
| Under $50K taxable, any bracket | Low-cost ETFs (VOO, VTI) | Fee premium eats the tax benefit |
| $50K–$100K, 24%+ bracket | Direct indexing (Wealthfront) | Modest but positive net benefit |
| $100K–$500K, 32%+ bracket | Direct indexing (Schwab/Vanguard) | Clear tax alpha, justified fees |
| $500K+, 35%+ bracket | Direct indexing + advisor | $7,500+/year net benefit |
| $500K+ concentrated stock | DI + Embark §721 SPV | DI for diversified; SPV for concentrated |
| All in 401(k)/IRA | Low-cost ETFs or target-date | No TLH benefit in tax-advantaged |
| Want ESG customization | Direct indexing (any size) | Customization value beyond tax |
For a deeper dive into any of these strategies, explore the rest of our direct indexing series — including detailed platform comparisons, tax alpha analysis, and RSU-specific strategies.
FAQ
Decision questions about direct indexing
What is the minimum portfolio size where direct indexing makes sense?
For pure tax-loss harvesting benefit: $100,000 in taxable accounts at the 32%+ tax bracket is the practical threshold where the net annual benefit (after fees) consistently exceeds $2,000. Some platforms accept $5,000 minimums, but the dollar benefit at that size is negligible. If you have specific customization needs (employer stock exclusion, ESG), the non-tax value may justify a lower starting point.
Should I use direct indexing for all my investments?
No. Use direct indexing only for the taxable portion of your portfolio. For 401(k), IRA, and Roth IRA, use low-cost ETFs (there's no tax benefit to harvesting in tax-advantaged accounts). For concentrated stock positions, use a dedicated strategy like Embark's §721 SPV. For fixed income, alternatives, and other non-equity assets, direct indexing doesn't apply.
Can I switch from ETFs to direct indexing without paying taxes?
If you hold ETFs with embedded gains, selling them to fund a direct indexing account triggers capital gains taxes. Two alternatives: (1) Transfer individual stock holdings in-kind if the platform accepts them, or (2) Start the direct indexing account with new cash and gradually transition by selling ETF lots with minimal gains or losses first. Some platforms can accept ETF shares and strategically liquidate them over time to minimize the tax impact.
I have concentrated stock AND a diversified portfolio. What should I do?
Use both strategies: direct indexing for the diversified taxable portfolio (harvests losses, excludes your employer's stock, generates 1–2% tax alpha). And Embark's §721 SPV for the concentrated position (defers the embedded capital gain, generates income, preserves upside). This combination ensures every dollar in your portfolio is tax-optimized — the diversified side harvests losses, the concentrated side defers gains and generates income. Schedule a review to build the plan.
Your Complete Strategy
Checked the Boxes? Let's Build the Plan.
If direct indexing fits your diversified portfolio, great — start there. If you also hold concentrated stock with large unrealized gains, Embark's §721 SPV is the complementary strategy. Schedule a review to build your personalized tax-optimized portfolio.